# Richmond Mutual Bancorporation, Inc.: financial statements, quarterly

RMBI · Nasdaq · CIK 1767837 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rmbi.md) · [Financials](/companies/rmbi/financials.md) · [Filings](/companies/rmbi/filings.md) · [Insiders](/companies/rmbi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rmbi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [8,286](/filings/0001767837-23-000027.md) | [9,250 d](/filings/0001767837-24-000007.md) | [9,677](/filings/0001767837-24-000010.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [274](/filings/0001767837-24-000018.md) | [235 d](/filings/0001767837-25-000006.md) | [352](/filings/0001628280-25-024374.md) | [305](/filings/0001628280-25-039314.md) | [369](/filings/0001628280-25-051153.md) | [460 d](/filings/0001628280-26-020414.md) | [348](/filings/0001628280-26-034155.md) | [382](/filings/0001628280-26-056785.md) | [645](/filings/0001628280-25-051153.md) | [701 d](/filings/0001628280-26-020414.md) | [562](/filings/0001628280-26-034155.md) | [436](/filings/0001628280-26-056785.md) |
| Net income | $k | [1,949](/filings/0001767837-24-000018.md) | [1,942 d](/filings/0001767837-25-000006.md) | [2,369](/filings/0001628280-25-024374.md) | [2,061](/filings/0001628280-25-039314.md) | [2,472](/filings/0001628280-25-051153.md) | [2,476 d](/filings/0001628280-26-020414.md) | [1,968](/filings/0001628280-26-034155.md) | [2,602](/filings/0001628280-26-056785.md) | [3,597](/filings/0001628280-25-051153.md) | [3,409 d](/filings/0001628280-26-020414.md) | [2,785](/filings/0001628280-26-034155.md) | [2,227](/filings/0001628280-26-056785.md) |
| Diluted EPS | $ per share | [0.19](/filings/0001767837-24-000018.md) | not reported | [0.23](/filings/0001628280-25-024374.md) | [0.20](/filings/0001628280-25-039314.md) | [0.24](/filings/0001628280-25-051153.md) | not reported | [0.20](/filings/0001628280-26-034155.md) | [0.26](/filings/0001628280-26-056785.md) | [0.36](/filings/0001628280-25-051153.md) | not reported | [0.28](/filings/0001628280-26-034155.md) | [0.22](/filings/0001628280-26-056785.md) |
| Basic EPS | $ per share | [0.19](/filings/0001767837-24-000018.md) | not reported | [0.23](/filings/0001628280-25-024374.md) | [0.20](/filings/0001628280-25-039314.md) | [0.25](/filings/0001628280-25-051153.md) | not reported | [0.20](/filings/0001628280-26-034155.md) | [0.27](/filings/0001628280-26-056785.md) | [0.37](/filings/0001628280-25-051153.md) | not reported | [0.29](/filings/0001628280-26-034155.md) | [0.23](/filings/0001628280-26-056785.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.7](/filings/0001767837-23-000027.md) | [20.2](/filings/0001767837-25-000006.md) | [20.3](/filings/0001767837-24-000010.md) | [19.0](/filings/0001767837-24-000015.md) | [19.6](/filings/0001767837-24-000018.md) | [21.8](/filings/0001628280-26-020414.md) | [27.0](/filings/0001628280-25-024374.md) | [27.2](/filings/0001628280-25-039314.md) | [34.3](/filings/0001628280-25-051153.md) | [33.1](/filings/0001628280-26-056785.md) | [34.8](/filings/0001628280-26-034155.md) | [34.7](/filings/0001628280-26-056785.md) |
| Total assets | $m | [1,423](/filings/0001767837-23-000027.md) | [1,461](/filings/0001767837-25-000006.md) | [1,488](/filings/0001767837-24-000010.md) | [1,495](/filings/0001767837-24-000015.md) | [1,493](/filings/0001767837-24-000018.md) | [1,505](/filings/0001628280-26-020414.md) | [1,523](/filings/0001628280-25-024374.md) | [1,508](/filings/0001628280-25-039314.md) | [1,526](/filings/0001628280-25-051153.md) | [1,526](/filings/0001628280-26-056785.md) | [1,519](/filings/0001628280-26-034155.md) | [1,552](/filings/0001628280-26-056785.md) |
| Total liabilities | $m | [1,304](/filings/0001767837-23-000027.md) | [1,326](/filings/0001767837-25-000006.md) | [1,355](/filings/0001767837-24-000010.md) | [1,364](/filings/0001767837-24-000015.md) | [1,353](/filings/0001767837-24-000018.md) | [1,372](/filings/0001628280-26-020414.md) | [1,392](/filings/0001628280-25-024374.md) | [1,375](/filings/0001628280-25-039314.md) | [1,386](/filings/0001628280-25-051153.md) | [1,380](/filings/0001628280-26-056785.md) | [1,374](/filings/0001628280-26-034155.md) | [1,404](/filings/0001628280-26-056785.md) |
| Shareholders' equity | $m | [119](/filings/0001767837-23-000027.md) | [135](/filings/0001767837-25-000006.md) | [132](/filings/0001767837-24-000010.md) | [131](/filings/0001767837-24-000015.md) | [140](/filings/0001767837-24-000018.md) | [133](/filings/0001628280-26-020414.md) | [131](/filings/0001628280-25-024374.md) | [132](/filings/0001628280-25-039314.md) | [140](/filings/0001628280-25-051153.md) | [146](/filings/0001628280-26-056785.md) | [145](/filings/0001628280-26-034155.md) | [148](/filings/0001628280-26-056785.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [1,926 d](/filings/0001767837-24-000018.md) | [3,789 d](/filings/0001767837-25-000006.md) | [2,162](/filings/0001628280-25-024374.md) | [2,917 d](/filings/0001628280-25-039314.md) | [2,882 d](/filings/0001628280-25-051153.md) | [6,791 d](/filings/0001628280-26-020414.md) | [2,181](/filings/0001628280-26-034155.md) | [4,844 d](/filings/0001628280-26-056785.md) | [6,277 d](/filings/0001628280-25-051153.md) | [2,667 d](/filings/0001628280-26-020414.md) | [2,786](/filings/0001628280-26-034155.md) | [3,029 d](/filings/0001628280-26-056785.md) |
| Capital expenditure | $k | [47.1 d](/filings/0001767837-24-000018.md) | [194 d](/filings/0001767837-25-000006.md) | [115](/filings/0001628280-25-024374.md) | [114 d](/filings/0001628280-25-039314.md) | [115 d](/filings/0001628280-25-051153.md) | [116 d](/filings/0001628280-26-020414.md) | [76.0](/filings/0001628280-26-034155.md) | [627 d](/filings/0001628280-26-056785.md) | [462 d](/filings/0001628280-25-051153.md) | [197 d](/filings/0001628280-26-020414.md) | [325](/filings/0001628280-26-034155.md) | [290 d](/filings/0001628280-26-056785.md) |
| Dividends paid | $k | [1,471 d](/filings/0001767837-24-000018.md) | [1,447 d](/filings/0001767837-25-000006.md) | [1,437](/filings/0001628280-25-024374.md) | [1,437 d](/filings/0001628280-25-039314.md) | [1,419 d](/filings/0001628280-25-051153.md) | [1,404 d](/filings/0001628280-26-020414.md) | [1,493](/filings/0001628280-26-034155.md) | [1,440 d](/filings/0001628280-26-056785.md) | [1,446 d](/filings/0001628280-25-051153.md) | [1,457 d](/filings/0001628280-26-020414.md) | [1,465](/filings/0001628280-26-034155.md) | [1,465 d](/filings/0001628280-26-056785.md) |
| Share repurchases | $k | [1,692 d](/filings/0001767837-24-000018.md) | [976 d](/filings/0001767837-25-000006.md) | [1,072](/filings/0001628280-25-024374.md) | [1,137 d](/filings/0001628280-25-039314.md) | [886 d](/filings/0001628280-25-051153.md) | [1,947 d](/filings/0001628280-26-020414.md) | [4,234](/filings/0001628280-26-034155.md) | [1,400 d](/filings/0001628280-26-056785.md) | [0.0 d](/filings/0001628280-25-051153.md) | [0.0 d](/filings/0001628280-26-020414.md) | [0.0](/filings/0001628280-26-034155.md) | [0.0 d](/filings/0001628280-26-056785.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.8](/filings/0001767837-23-000027.md) | [10.7](/filings/0001767837-24-000010.md) | [10.5](/filings/0001767837-24-000015.md) | [10.4](/filings/0001767837-24-000018.md) | [10.2](/filings/0001628280-25-024374.md) | [10.2](/filings/0001628280-25-039314.md) | [10.2](/filings/0001628280-25-051153.md) | [10.1](/filings/0001628280-26-034155.md) | [9.8](/filings/0001628280-26-056785.md) | [9.9](/filings/0001628280-25-051153.md) | [9.9](/filings/0001628280-26-034155.md) | [9.9](/filings/0001628280-26-056785.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,759,046 at 2026-08-13, from the cover of the [10-Q filed 2026-08-13](/filings/0001628280-26-056785.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.